Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
14.21
-0.21 (-1.46%)
At close: Apr 25, 2025, 4:00 PM
14.15
-0.06 (-0.42%)
Pre-market: Apr 28, 2025, 7:44 AM EDT
Keros Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$25.29
Upside
+77.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $43 → $25 | Strong Buy | Maintains | $43 → $25 | +75.93% | Apr 9, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | +5.56% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +181.49% | Apr 1, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +82.97% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $40 | Strong Buy | Maintains | $47 → $40 | +181.49% | Feb 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $40 → $15 | Buy | Maintains | $40 → $15 | +5.56% | Jan 17, 2025 |
| Wedbush | Wedbush | Buy → Hold Downgrades $47 → $15 | Buy → Hold | Downgrades | $47 → $15 | +5.56% | Jan 17, 2025 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 17, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $44 → $41 | Buy | Maintains | $44 → $41 | +188.53% | Jan 16, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $63 → $23 | Buy | Maintains | $63 → $23 | +61.86% | Jan 16, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $100 → $43 | Strong Buy | Maintains | $100 → $43 | +202.60% | Dec 23, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $102 → $63 | Buy | Maintains | $102 → $63 | +343.35% | Dec 16, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 16, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $11 → $28 | Buy | Maintains | $11 → $28 | +97.04% | Dec 13, 2024 |
| Scotiabank | Scotiabank | Buy Maintains $77 → $44 | Buy | Maintains | $77 → $44 | +209.64% | Dec 13, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.